223 results match your criteria: "Centre Hospitalier Universitaire Dijon[Affiliation]"
J Gerontol A Biol Sci Med Sci
July 2021
Service de Médecine Interne Gériatrie, Centre Hospitalier Universitaire Dijon Bourgogne, France.
Clin Genet
May 2021
Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Hôpital d'Enfants, CHU Dijon, Dijon, France.
Megalencephaly-CApillary malformation-Polymicrogyria (MCAP) syndrome results from somatic mosaic gain-of-function variants in PIK3CA. Main features are macrocephaly, somatic overgrowth, cutaneous vascular malformations, connective tissue dysplasia, neurodevelopmental delay, and brain anomalies. The objectives of this study were to describe the clinical and radiological features of MCAP, to suggest relevant clinical endpoints applicable in future trials of targeted drug therapy.
View Article and Find Full Text PDFJ Mol Diagn
April 2021
Laboratory of Parasitology and Mycology, Centre Hospitalier Universitaire de Clermont-Ferrand, Infection Inflammation et Interaction Hôtes Pathogènes, Clermont-Ferrand, France; Université Clermont Auvergne, Centre National de la Recherche Scientifique, Laboratoire Microorganismes: Génome et Environnement, Clermont-Ferrand, France. Electronic address:
Microsporidiosis and cryptosporidiosis are associated with chronic diarrhea in immunocompromised patients. The objectives of this study were to: i) assess a multiplex quantitative PCR assay targeting Cryptosporidium spp and the microsporidian Enterocytozoon bieneusi and Encephalitozoon spp, and ii) provide an update on the epidemiology of these pathogens. A prospective study was conducted from January 2017 to January 2019.
View Article and Find Full Text PDFJ Am Med Dir Assoc
February 2021
Service de médecine geriatrique aigue, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.
Clin Genet
April 2021
Service de Génétique, Angers Cedex 9, France.
Immunotherapy
February 2021
Erasmus University Medical Center Cancer Institute, Rotterdam 3015 GD, The Netherlands.
To compare daratumumab plus standard-of-care (SoC; bortezomib/thalidomide/dexamethasone [VTd]) and VTd alone with other SoC for transplant-eligible newly diagnosed multiple myeloma. We conducted an unanchored matching-adjusted indirect comparison of progression-free and overall survival (PFS/OS) with D-VTd/VTd versus bortezomib/lenalidomide/dexamethasone (VRd), bortezomib/cyclophosphamide/dexamethasone (VCd) and bortezomib/dexamethasone (Vd). After matching adjustment, significant improvements in PFS were estimated for D-VTd versus VRd (hazard ratio [HR]: 0.
View Article and Find Full Text PDFClin Microbiol Infect
March 2021
Department of Neurology, Centre Hospitalier de Saint-Denis, Hôpital Delafontaine, Saint-Denis, France.
Objectives: To provide an overview of the spectrum, characteristics and outcomes of neurologic manifestations associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Methods: We conducted a single-centre retrospective study during the French coronavirus disease 2019 (COVID-19) epidemic in March-April 2020. All COVID-19 patients with de novo neurologic manifestations were eligible.
J Clin Med
November 2020
Geriatrics Internal Medicine Department, Centre Hospitalier Universitaire Dijon Bourgogne, 21000 Dijon, France.
Cardiovascular (CV) events are particularly frequent after acute pneumonia (AP) in the elderly. We aimed to assess whether cardiac troponin I, a specific biomarker of myocardial injury, independently predicts CV events and death after AP in older inpatients. Among 214 consecutive patients with AP aged ≥75 years admitted to a university hospital, 171 with a cardiac troponin I sample in the 72 h following diagnosis of AP were included, and 71 (42%) were found to have myocardial injury (troponin > 100 ng/L).
View Article and Find Full Text PDFJ Am Acad Dermatol
December 2020
Sorbonnes Universités Pierre et Marie Curie, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de médecine Interne et d'immunologie clinique, Paris, France; Institut National de la Santé et de la Recherche Médicale, UMR974, Paris, France. Electronic address:
Diagn Interv Imaging
December 2020
Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, 69003 Lyon, France; Department of Radiology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, 69310 Pierre-Bénite, France; CREATIS, CNRS UMR 5220, INSERM U1044, 69622 Villeurbanne, France.
Purpose: The purpose of this study was to create an algorithm that combines multiple machine-learning techniques to predict the expanded disability status scale (EDSS) score of patients with multiple sclerosis at two years solely based on age, sex and fluid attenuated inversion recovery (FLAIR) MRI data.
Materials And Methods: Our algorithm combined several complementary predictors: a pure deep learning predictor based on a convolutional neural network (CNN) that learns from the images, as well as classical machine-learning predictors based on random forest regressors and manifold learning trained using the location of lesion load with respect to white matter tracts. The aggregation of the predictors was done through a weighted average taking into account prediction errors for different EDSS ranges.
J Psychosom Res
August 2020
Northwestern Scleroderma Program, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Objective: Contagious disease outbreaks and related restrictions can lead to negative psychological outcomes, particularly in vulnerable populations at risk due to pre-existing medical conditions. No randomised controlled trials (RCTs) have tested interventions to reduce mental health consequences of contagious disease outbreaks. The primary objective of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Trial is to evaluate the effect of a videoconference-based program on symptoms of anxiety.
View Article and Find Full Text PDFOrphanet J Rare Dis
May 2020
Service de pneumologie, Centre hospitalier universitaire vaudois, Université de Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Background: Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on lung function in BHD are scarce and it is not known whether lung function declines over time.
View Article and Find Full Text PDFNat Commun
May 2020
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
KIF21B is a kinesin protein that promotes intracellular transport and controls microtubule dynamics. We report three missense variants and one duplication in KIF21B in individuals with neurodevelopmental disorders associated with brain malformations, including corpus callosum agenesis (ACC) and microcephaly. We demonstrate, in vivo, that the expression of KIF21B missense variants specifically recapitulates patients' neurodevelopmental abnormalities, including microcephaly and reduced intra- and inter-hemispheric connectivity.
View Article and Find Full Text PDFJ Med Genet
December 2020
Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, Dijon, France.
Introduction: Pigmentary mosaicism (PM) manifests by pigmentation anomalies along Blaschko's lines and represents a clue toward the molecular diagnosis of syndromic intellectual disability (ID). Together with new insights on the role for lysosomal signalling in embryonic stem cell differentiation, mutations in the X-linked transcription factor 3 () have recently been reported in five patients. Functional analysis suggested these mutations to result in ectopic nuclear gain of functions.
View Article and Find Full Text PDFBiom J
October 2020
Service de Biostatistique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Treatment selection markers are generally sought for when the benefit of an innovative treatment in comparison with a reference treatment is considered, and this benefit is suspected to vary according to the characteristics of the patients. Classically, such quantitative markers are detected through testing a marker-by-treatment interaction in a parametric regression model. Most alternative methods rely on modeling the risk of event occurrence in each treatment arm or the benefit of the innovative treatment over the marker values, but with assumptions that may be difficult to verify.
View Article and Find Full Text PDFEur Ann Otorhinolaryngol Head Neck Dis
November 2020
Service d'Anatomo-pathologie, Centre hospitalier universitaire Dijon-Bourgogne, 14, rue Paul-Gaffarel, 21000 Dijon, France.
Clin Genet
July 2020
INSERM UMR1231, Equipe Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
J Med Genet
July 2020
INSERM, U1231, Génétique des Anomalies du Développement, Université de Bourgogne Franche-Comté, UMR Lipides, Nutrition, Dijon, France
J Am Acad Dermatol
December 2020
Sorbonne Universités Pierre et Marie Curie, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de médecine Interne et d'immunologie clinique, France; Institut National de la Santé Et de la Recherche Médicale, Unité Mixte de Recherche 974, Paris, France. Electronic address:
N Engl J Med
March 2020
Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
Rev Mal Respir
March 2020
Inserm U1231, faculté de médecine et de pharmacie, université de Bourgogne-Franche Comté, 21000 Dijon, France.
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease without therapeutic options. The development of new therapeutic strategies for the disease is needed. IPF is characterized by myofibroblast accumulation and collagen overproduction.
View Article and Find Full Text PDFN Engl J Med
February 2020
Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France
Front Bioeng Biotechnol
January 2020
INSERM, CIC 1432, Module Plurithematique, Plateforme d'Investigation Technologique, Dijon, France; CHU Dijon-Bourgogne, Centre d'Investigation Clinique, Module Plurithématique, Plateforme d'Investigation Technologique, Dijon, France.
Nat Genet
March 2020
Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement, Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France.
J Neuroradiol
June 2020
MRI center, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France; Observatoire Français de la Sclérose en Plaques, Lyon, France; Université Lyon 1, CREATIS-LRMN, CNRS/UMR/5220-INSERM U630, Villeurbanne, France.
Purpose: New multiple sclerosis (MS) disease-modifying therapies (DMTs), which exert beneficial effects through prevention of relapse, limitation of disability progression, and improvement of patients' quality of life, have recently emerged. Nonetheless, these DMTs are not without associated complications (severe adverse events like. progressive multifocal leukoencephalopathy).
View Article and Find Full Text PDF